【邱俊吉/台北報導】罕見疾病醫學研究又見突破。馬偕醫院推動大規模第1型黏多醣症新生兒篩檢計畫,成功在疾病未發前確診2名新生兒患者,未來透過追蹤、選擇適當療法等,可望避免此症造成不可逆傷害,這項研究成果也獲國際學術界肯定,已登於最新一期罕病權威期刊《Orphanet Journal of Rare Diseases》。
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends:
留言列表